Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05654974
Other study ID # 0000187
Secondary ID
Status Completed
Phase
First received
Last updated
Start date December 1, 2019
Est. completion date January 31, 2021

Study information

Verified date December 2022
Source University Medical Center, Kazakhstan
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Purpose: to assess in Kazakh adult males erect penis sizes, and study an influence of their natural physiological events and behavioral habits during their growing ages on their penile sizes nowadays. Study Design: An observational cross-sectional survey pilot study using a correlational design with the intention-to-treat principle.


Description:

Participants. A total of 282 adult Kazakh males from the Republic of Kazakhstan and who have been visited at the urology units of three university centers in the biggest cities of the Republic of Kazakhstan (Astana, Almaty, and Karaganda) were prospectively included in the study, which took place between January 2020 and January 2021. Measurements of the penis erect length and girth were by two doctor-urologists according to the method of Veale D et al. (2015). Statistical analysis. Two-tailed Student's t-test, Pearson correlation and multivariate tests of the MANOVA and MANCOVA (body height as covariate) were used. Sample size estimation. In a cross-sectional observational study in assessment of erect penis size of Kazakh adult males we supposed that the primary interest lies in assessment of erect penis sizes in the three cities (k=3). The investigators wish to be 95% sure of detecting when the mean erect penis sizes not exceed 1 mm (i.e., 1-β=0.95, and m1=1, m2=0). The standard deviation of erect penis size is likely to be 1.56 mm (i.e. SD=1.56) with a statistical power of 95% and significance level of 2.5% with the Bonferroni correction based on one-sided hypothesis testing. At the 5% Type I error rate (i.e., α=0.05), the sample size of the survey is 196.


Recruitment information / eligibility

Status Completed
Enrollment 282
Est. completion date January 31, 2021
Est. primary completion date November 30, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 23 Years to 35 Years
Eligibility Inclusion Criteria: - male gender aged from 23 to 35 years - fill out the questionnaire - BMI = 29.9 kilogram per meter square - a male who has at least one healthy native child - no non-communicable chronic diseases. Exclusion Criteria: - female gender - BMI = 30.0 kilogram per meter square - infertility - erectile dysfunction, previous pelvic surgery, suspected hypogonadism, penile disease, or deformity - specific treatment with androgens - alcohol or drug abuse - history of alcohol consumption = 30 g/day within the past 5 years.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
measurements and questionnaire
paper-based survey administration; erect penis length and girth measurements

Locations

Country Name City State
Kazakhstan Kuat Pernekulovich Oshakbayev Astana

Sponsors (1)

Lead Sponsor Collaborator
University Medical Center, Kazakhstan

Country where clinical trial is conducted

Kazakhstan, 

Outcome

Type Measure Description Time frame Safety issue
Primary erect penis length and girth centimeter baseline
See also
  Status Clinical Trial Phase
Completed NCT03995849 - Motion of Kids on Radiation Treatment
Recruiting NCT05359367 - A Novel Approach to Enhance True Recovery After Stroke
Not yet recruiting NCT05135013 - The Association of Hormonal Intake and Demographic Factors With Breast Cancer Risk. An Egyptian Case-controlled Study
Completed NCT03233789 - Development and Validation of an ADL-score Based on FIM and EBI
Not yet recruiting NCT06361602 - Exploring the Effectiveness and Factors Affecting the Collection of Single Nucleated Cells From Different Volunteers
Recruiting NCT01983059 - Swiss Liver Venous Thrombosis Study
Recruiting NCT06316752 - The Natural History of Sialidosis Type I
Recruiting NCT04115137 - Pelvic Varicose Veins Treated With Vascular Plugs Type Amplatzer: REPiVAC
Completed NCT03417804 - Incidence of Postoperative Residual Neuromuscular Blockade in Portugal
Terminated NCT03869645 - CAPERE Thrombectomy System Post-Market Clinical Follow Up Study
Completed NCT01956539 - FREnch Survey on Heart Failure
Completed NCT02029144 - Observational Study of Dydrogesterone in Cycle Regularization N/A